Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Int. braz. j. urol ; 39(2): 173-181, Mar-Apr/2013. tab, graf
Article in English | LILACS | ID: lil-676256

ABSTRACT

Purpose A growing body of evidence suggests that low testosterone can be an independent predictor of adverse clinicopathological features and worse prognosis in prostate cancer (PCa) patients. However, this association is still incompletely understood and the results are divisive. The aim of this study was to analyze testosterone as a predictor of aggressive disease in subjects with clinically localized PCa. Materials and Methods A cohort was conducted including the patients submitted to radical prostatectomy in our institution during a period of four years. The patients had clinically localized disease and their total testosterone (TT) was routinely measured preoperatively in the morning before surgery. They were stratified in groups with low (< 300 ng/dL) and normal TT (≥ 300 ng/dL). Tumor aggressiveness was inferred based on preoperative PSA levels, pathological Gleason score (lower, equal or greater than 7), TNM stage and surgical margins status. Results After analyzing 164 patients we found a significant association between mean preoperative TT and extraprostatic disease (379 for pT3 vs. 421 ng/for pT2 - p < 0.001, AUC > 0.99). Conversely, men with high Gleason score had similar mean TT compared to those with lower scores. Preoperative low TT (defined as TT < 300 ng/dL) could not be statistically correlated with either preoperative PSA levels, pathological Gleason score, extraprostatic extension, positive surgical margins or seminal vesicles involvement. Conclusions This study indicates that testosterone may be a useful predictive tool once pathological extraprostatic extension was somewhat signaled by lower TT levels preoperatively. However, it does not consolidate a clear association between aggressive tumor biology and hypogonadism. .


Subject(s)
Adult , Aged , Humans , Male , Middle Aged , Prostatic Neoplasms/blood , Prostatic Neoplasms/pathology , Testosterone/blood , Biomarkers, Tumor/blood , Neoplasm Grading , Predictive Value of Tests , Prognosis , Prospective Studies , Prostatectomy , Prostate-Specific Antigen/blood , Prostatic Neoplasms/surgery , Statistics, Nonparametric , Testosterone/deficiency , Biomarkers, Tumor/deficiency
2.
Rev. Soc. Bras. Med. Trop ; 42(5): 581-582, Sept.-Oct. 2009. ilus
Article in English | LILACS | ID: lil-532517

ABSTRACT

The relationship between bladder tumors and Schistosoma haematobium is well known, but only sporadic cases of bladder infection due to Schistosoma mansoni have been reported. In this case, a 48-year-old woman with macroscopic hematuria, dysuria and a palpable abdominal mass was investigated. Ultrasound showed a large exophytic mass in the bladder. Transurethral resection of the bladder revealed viable eggs of Schistosoma mansoni. The patient was treated clinically with oxamniquine and surgery was performed to resect the large mass. This case shows that schistosomiasis Mansoni in the bladder can simulate bladder cancer.


É bem conhecida a relação entre tumor vesical e Schistosoma haematobium, porém somente casos esporádicos de infecção vesical por Schistosoma mansoni foram relatados. Neste caso, uma mulher de 48 anos com hematúria macroscópica, disúria e massa abdominal palpável foi investigada, ultra-sonografia mostrou uma grande massa exofítica na bexiga. A ressecção transuretral de bexiga evidenciou ovos viáveis de Schistosoma mansoni. A paciente foi tratada clinicamente com oxaminiquine e uma cirurgia foi realizada para ressecar a grande massa. Este caso mostra que a esquistossomose mansônica vesical pode simular um câncer vesical.


Subject(s)
Animals , Female , Humans , Middle Aged , Schistosoma mansoni/isolation & purification , Schistosomiasis mansoni/diagnosis , Urinary Bladder Diseases/parasitology , Diagnosis, Differential , Oxamniquine/therapeutic use , Schistosomiasis mansoni/drug therapy , Schistosomicides/therapeutic use , Urinary Bladder Diseases/diagnosis , Urinary Bladder Neoplasms/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL